Management of Small Bowel Neuroendocrine Tumors

Several important landmark trials have reshaped the landscape of non-surgical management of small bowel neuroendocrine tumors over the last few years, with the confirmation of the antitumor effect of somatostatin analogue therapy in PROMID and CLARINET trials as well as the advent of therapies with...

Descripción completa

Detalles Bibliográficos
Autores principales: Larouche, Vincent, Akirov, Amit, Alshehri, Sameerah, Ezzat, Shereen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770692/
https://www.ncbi.nlm.nih.gov/pubmed/31540509
http://dx.doi.org/10.3390/cancers11091395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770692/
https://www.ncbi.nlm.nih.gov/pubmed/31540509
http://dx.doi.org/10.3390/cancers11091395

Ejemplares similares